Karl Deres

Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells

Olaf Rötzschke, Kirsten Falk, Karl Deres et al. · Nature · 1990 · 771 citations

Cytotoxic T Cells, Human Retrovirus, Immunology +8

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

Karl Deres, Hansjörg Schild, Karl‐Heinz Wiesmüller et al. · Nature · 1989 · 633 citations · Full text

Vaccination, Mucosal Vaccination, Synthetic Lipopeptide Vaccine +8

Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of Nucleocapsids

Karl Deres, Claus H. Schröder, Arnold Paessens et al. · Science · 2003 · 502 citations

Immunology, Hepatitis B, Molecular Biology +18

Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast.

Kirsten Falk, Olaf Rötzschke, Karl Deres et al. · The Journal of Experimental Medicine · 1991 · 266 citations · Full text

Adaptive Immune System, Immunology, Antigen Processing +19

Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model

Olaf Weber, K.-H. Schlemmer, Enno Hartmann et al. · Antiviral Research · 2002 · 162 citations

Hepatology, Novel Non-nucleosidic Compound, Viral Hepatitis +11